OCT Therapies and Research

OCT Therapies and Research is a biotechnology company focused on the development of advanced cell-based therapies to treat chronic and degenerative diseases. The company specializes in the isolation, expansion, and clinical application of mesenchymal stem cells (MSCs) derived from various human tissues. Their primary research and development efforts target high-unmet-need conditions such as critical limb ischemia, diabetic foot ulcers, and orthopedic injuries. By leveraging proprietary processing techniques, OCT Therapies aims to provide regenerative medicine solutions that improve patient outcomes and reduce the burden of chronic disability.